Worcester, MANCT02050113Now EnrollingIRB Ready

Complex Aortic Aneurysms Clinical Trial in Worcester, MA

Access cutting-edge complex aortic aneurysms treatment through this clinical trial at a research site in Worcester. Study-provided care at no cost to qualified participants.

Sponsored by Andres Schanzer

Quick Self-Assessment

See if you qualify for this Worcester location

Preparing your pre-screening questions…

Expert Care in Worcester

Access complex aortic aneurysms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related complex aortic aneurysms treatment provided free

Apply for This Worcester Location

Check if you qualify for this complex aortic aneurysms clinical trial in Worcester, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Worcester

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Worcester site if eligible
  4. 4Begin participation

About This Complex Aortic Aneurysms Study in Worcester

The purpose of this study is to evaluate the safety and efficacy of custom made devices, Zenith t-Branch devices and physician modification of FDA approved off-the-shelf endovascular grafts in the treatment of patients with complex abdominal aneurysms, aortoiliac aneurysms, thoracoabdominal aneurysms and aortic arch aneurysms who (1) have anatomy not suitable for endovascular repair using grafts currently marketed in the United States,(2) are deemed unsafe to wait the required time necessary for commercial endograft manufacturing, and (3) are at high risk for open surgical repair. Amendment to the study has created a cohort open to people with connective tissue diseases such as Marfan, Ehlers-Danlos or Loey-Dietz syndromes to enroll in the trial. An additional amendment to the study allows the use of a custom made device to treat an aneurysm in the aortic arch.

Sponsor: Andres Schanzer

Who Can Participate

Inclusion Criteria

A patient may be suitable for inclusion in the study if the patient has at least one of the following:
Aortic or aortoiliac aneurysm with diameter ≥5.5 cm
Aortic or aortoiliac aneurysm with a history of growth ≥1.0 cm per year, or clinical indication for aneurysm repair based on symptoms General Inclusion Criteria <!-- -->
Cannot be treated with a currently available non-modified approved device
Symptomatic on presentation and unsafe to wait for the time necessary to obtain a currently available non-modified approved device
At least 18 years of age
Not pregnant or breastfeeding
Willing and able to comply with five years of follow-up
Willing and able to provide informed consent prior to enrollment
No systemic or local infection that may increase the risk of endovascular graft infection
High risk for open surgical repair based on any of the factors below: a. Anatomic i. Previous abdominal surgery ii. Previous left-sided thoracotomy (if the proposed open repair would require dissection of the thoracic aorta) iii. Previous aortic surgery b. Physiologic i. ASA Category III or higher ii. Age \>70 years iii. Previous myocardial infarction, coronary artery disease, or coronary artery stent iv. Coronary stress test with a reversible perfusion defect v. Congestive heart failure vi. COPD

Exclusion Criteria

Cultural objection to receipt of blood or blood products
Allergy or sensitivity to stainless steel, polyester, polypropylene, solder (tin, silver), gold, or nitinol
Anaphylactic reaction to contrast that cannot be adequately pre-medicated
Uncorrectable coagulopathy
Unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina)
Patient has active malignancy with life expectancy of less than 2 years
Patient has life expectancy less than two years Anatomical Exclusion Criteria
Significant occlusive disease, tortuosity, or calcification that would prevent endovascular access
Proximal neck length ≤25 mm
Proximal neck, measured outer wall to outer wall on a sectional image (CT)
For use of Zenith Flex: diameter \>32 mm or \<18 mm
For use of Zenith TX2: diameter \>38 mm or \<24 mm (for proximal and distal neck diameter)
Proximal neck angulated more than 60 degrees relative to the long axis of the aneurysm
Proximal neck diameter change over the length of the proximal seal zone \>4 mm
Proximal seal site with a circumferential thrombus/atheroma
Iliac artery diameter, measured inner wall to inner wall on a sectional image (CT) \<7.0 mm at any point along access length (prior to deployment)
Ipsilateral iliac artery fixation site diameter, measured inner wall on a sectional image (CT) \>21 mm at distal fixation site
Iliac artery distal fixation site \<10 mm in length
Non-bifurcated segment of any artery to be stented \< 15 mm in length
Artery to be stented with a maximum diameter \<3 mm or \>10 mm at the vessel ostium
Inability to maintain at least one patent hypogastric artery

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Worcester?

Yes, this clinical trial (NCT02050113) has an active research site in Worcester, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Complex Aortic Aneurysms Treatment Options in Worcester, MA

If you're searching for complex aortic aneurysms treatment options in Worcester, MA, this clinical trial (NCT02050113) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Worcester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced complex aortic aneurysms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all complex aortic aneurysms clinical trials near you to find additional studies recruiting in your area.

More Aortic Aneurysm Trials in Worcester, MA

See all aortic aneurysm clinical trials recruiting in Worcester — not just this study.

Browse Aortic Aneurysm Trials in Worcester

Ready to Join in Worcester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Worcester, MA